25 results
CORRESP
LRMR
Larimar Therapeutics Inc
20 Jun 14
Correspondence with SEC
12:00am
completed our long-term chronic toxicology studies in rat and dog, and we plan to submit the results of such studies, along with other information, to the FDA
8-K
EX-99.1
LRMR
Larimar Therapeutics Inc
16 Oct 15
Zafgen Announces Partial Clinical Hold Affecting Beloranib Trials
12:00am
and function, short stature, incomplete sexual development, and a chronic feeling of hunger that, when coupled with a metabolism that utilizes
10-K
opk188s
25 Mar 15
Annual report
12:00am
424B5
pnt8eejttoq8v4k
9 Nov 18
Prospectus supplement for primary offering
4:49pm
424B4
nax b1d0za
19 Jun 14
Prospectus supplement with pricing info
12:00am
424B5
fyhqk6o29 e2hrz
28 Jun 18
Prospectus supplement for primary offering
4:54pm
424B5
08w4teh vlh6x8kyp94
27 Jun 18
Prospectus supplement for primary offering
4:49pm